Novavax WKN: A2PKMZ ISIN: US6700024010 Kürzel: NVAX Forum: Aktien Thema: Hauptdiskussion
6,98 EUR
+0,29 %+0,02
16. Nov, 13:00:56 Uhr,
Lang & Schwarz
Kommentare 194.573
l
lilli88,
24.06.2024 16:28 Uhr
2
GAITHERSBURG, Md., June 24, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that it has filed for a type II variation of existing Marketing Authorization with the European Medicines Agency (EMA) for its JN.1 COVID-19 vaccine (NVX-CoV2705) for individuals aged 12 and older. The submission is in line with guidance from EMA and the World Health Organization to target the JN.1 lineage this fall.1,2
"Novavax is working closely with European markets seeking to offer a protein-based alternative to mRNA this fall for COVID-19 vaccination," said John C. Jacobs, President and Chief Executive Officer, Novavax. "Our updated COVID-19 vaccine is active against current circulating strains, including KP.2 and KP.3."
Nonclinical data have demonstrated that Novavax's JN.1 COVID-19 vaccine induces broad neutralization responses to JN.1 lineage viruses, including those containing the F456L and R346T mutations, and to "FLiRT" and "FLuQE" variants.2-4 Novavax's vaccine also produces conserved polyfunctional, Th1-biased CD4+ T cell responses to a range of JN.1 lineage variants.2 Novavax's JN.1 COVID-19 vaccine targets the "parent strain" of KP.2 and KP.3.2
Novavax intends to have its vaccine in unit-dose vials available for distribution in the European Union for immediate release post-approval. Novavax has also filed with the U.S. Food and Drug Administration (FDA) and is working with other regulatory authorities globally on authorization or approval of its JN.1 COVID-19 vaccine.
https://finance.yahoo.com/news/novavax-submits-application-european-medicines-131800977.html?_fsig=tHwOH8zgxBYUdZB23gxRug--%7EA
Newe,
24.06.2024 16:27 Uhr
0
Klasse, der Anstieg hat ja mal wieder keine Stunde gehalten 🙄
W
l
lilli88,
24.06.2024 16:09 Uhr
0
Gucci auf wish bestellt
Newe,
24.06.2024 16:08 Uhr
0
Da hat die Handtasche wohl schon wieder einen neuen Account gebraucht 🤦🏼♂️
DeVita,
24.06.2024 16:07 Uhr
1
Auf geht’s 🤑🤑🤑🤑🔥🔥🔥🔥🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🧨🧨🧨🧨🧨🧨🧨🧨🧨🧨
DeVita,
24.06.2024 16:06 Uhr
0
Was is den da los 🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🔥🔥🔥🔥🔥🔥🔥🔥🔥
l
M
Mehr zu diesem Wert
|
Thema | ||
---|---|---|---|
1 | Novavax Hauptdiskussion | ||
2 | Hauptforum Novavax | ||
3 | Mission 920€ - Short Squeeze | ||
4 | Novavax - Insolvenz möglich? | ||
5 | 🍀Allgemeine Themen und Tipps🍀 | ||
6 | langweilige Rentneraktien | ||
7 | Link zum Novavax Austausch |
Meistdiskutiert
|
Thema | ||
---|---|---|---|
1 | Goldpreis Hauptdiskussion | ±0,00 % | |
2 | MicroStrategy | +0,43 % | |
3 | Ripple Hauptdiskussion | +35,89 % | |
4 | [ ₿ ] KRYPTOWÄHRUNGEN | -0,79 % | |
5 | Börsen Comedy | ||
6 | DEUTSCHE BANK Hauptdiskussion | ±0,00 % | |
7 | Carisma Therapeutics Hauptdiskussion | ±0,00 % | |
8 | XRP zu USD Hauptdiskussion | +34,17 % | |
9 | EVOTEC Hauptdiskussion | +0,24 % | |
10 | Super Micro Computer Hauptdiskussion | +18,29 % | Alle Diskussionen |
Aktien
|
Thema | ||
---|---|---|---|
1 | MicroStrategy | +0,43 % | |
2 | DEUTSCHE BANK Hauptdiskussion | ±0,00 % | |
3 | Carisma Therapeutics Hauptdiskussion | ±0,00 % | |
4 | Super Micro Computer Hauptdiskussion | +18,29 % | |
5 | EVOTEC Hauptdiskussion | +0,24 % | |
6 | BioNTech Hauptdiskussion | -0,08 % | |
7 | VITAL THERAPIES Hauptdiskussion | -0,99 % | |
8 | NETFLIX Hauptdiskussion | +0,04 % | |
9 | Verastem | -1,05 % | |
10 | URANIUM ENERGY Hauptdiskussion | ±0,00 % | Alle Diskussionen |